Ranbaxy said it is taking specific actions to address certain conduct of the past
Video Released on Gout Awareness Day Aims to Dispel Outdated Perceptions
Study Shows Effects of Treatment with ABILIFY MAINTENA™ (Aripiprazole) on Psychiatric Hospitalization Rates for Patients with Schizophrenia...
Vortioxetine, a new multimodal agent in development for the treatment of major depression, shows effects on cognitive function in several preclinical...
As the US Senate considers legislation to toughen oversight of compounding pharmacies, one group of physicians is lobbying the Senate to create an...
And so another exciting day winds down, which means the time has come to kick back, watch a movie, kick back a stiff potion and do a little reading. First, though, we leave you with these....
Tysabri Is Backed By FDA Panel, But With Restrictions (Bloomberg News)
Court Considers Wyeth Motion To Prevent Generic Protonix (press release)
Cephalon Posts A Loss On Settlement Reserve (Bloomberg News)
1 Comment
Jim Cramer is not worried about Tysabri safety for approval: http://www.stocktagger.com/2007/08/cramer-finally-bullish-on-elan.html